Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Pb Multiple | 1.1x - 1.2x | 1.1x |
Historical Pb Multiple | 0.8x - 1.9x | 1.3x |
Fair Value | €0.42 - €0.46 | €0.44 |
Upside | 27.8% - 41.2% | 34.5% |
Benchmarks | - | Full Ticker |
Danieli & C. Officine Meccaniche S.p.A. | - | BIT:DAN |
GVS S.p.A. | - | BIT:GVS |
Ecomembrane S.p.A. | - | BIT:ECMB |
Antares Vision S.p.A. | - | BIT:AV |
Comer Industries S.p.A. | - | BIT:COM |
Fidia S.p.A. | - | BIT:FDA |
Select Price / Book Ratio | ||||||||
Benchmark Companies | ||||||||
DAN | GVS | ECMB | AV | COM | FDA | |||
BIT:DAN | BIT:GVS | BIT:ECMB | BIT:AV | BIT:COM | BIT:FDA | |||
Historical Net Income Growth | ||||||||
5Y CAGR | 29.2% | 0.2% | NM- | NM- | 29.4% | NM- | ||
3Y CAGR | 44.3% | -21.0% | -51.5% | NM- | 19.5% | NM- | ||
Latest Twelve Months | 1.5% | 25.7% | -85.9% | 81.2% | -28.5% | -611.4% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 4.8% | 11.8% | 5.7% | -5.6% | 6.7% | -15.3% | ||
Prior Fiscal Year | 6.0% | 3.2% | 7.6% | -47.4% | 7.7% | -4.5% | ||
Latest Fiscal Year | 5.6% | 7.8% | 0.8% | -9.0% | 7.1% | -53.0% | ||
Latest Twelve Months | 6.3% | 6.0% | 0.8% | -9.0% | 7.1% | -53.0% | ||
Return on Equity | ||||||||
5 Year Average Margin | 7.7% | 17.3% | 2.1% | -6.2% | 18.0% | -64.6% | ||
Prior Fiscal Year | 10.5% | 4.1% | 7.9% | -45.2% | 19.8% | -28.5% | ||
Latest Twelve Months | 10.3% | 6.5% | 1.1% | -11.5% | 12.8% | -301.7% | ||
Next Fiscal Year | 9.2% | 10.5% | 6.4% | 6.9% | 11.0% | #NUM! | ||
Two Fiscal Years Forward | 8.8% | 10.8% | 8.5% | 9.2% | 13.2% | 545.7% | ||
Current Trading Multiples | ||||||||
Price / LTM Sales | 0.5x | 2.3x | 1.1x | 1.5x | 1.0x | 0.1x | ||
Price / LTM EPS | 8.6x | 39.1x | 129.3x | -16.6x | 13.7x | -0.3x | ||
Price / Book | 0.8x | 2.3x | 1.4x | 1.9x | 1.7x | 0.8x | ||
Price / Fwd Book | 0.8x | 2.0x | 1.3x | 1.8x | 1.6x | 0.8x | ||
Low | Mid | High | ||||||
Benchmark P/B Ratio | 0.8x | 1.7x | 2.3x | |||||
Historical P/B Ratio | 0.8x | 1.3x | 1.9x | |||||
Selected P/B Multiple | 1.1x | 1.1x | 1.2x | |||||
(x) Book Value | 3 | 3 | 3 |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | DAN | GVS | ECMB | AV | COM | FDA | |
Value of Common Equity | 2,308 | 1,010 | 21 | 311 | 920 | 2 | |
(/) Shares Outstanding | 65.7 | 188.9 | 4.3 | 71.0 | 28.7 | 7.5 | |
Implied Stock Price | 35.15 | 5.35 | 4.98 | 4.38 | 32.10 | 0.33 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 35.15 | 5.35 | 4.98 | 4.38 | 32.10 | 0.33 | |
Trading Currency | EUR | EUR | EUR | EUR | EUR | EUR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |